The development comes as the U.S. military is drawing up options for President Trump to consider, including possible strikes inside the country. By Julian E. Barnes and Tyler Pager Reporting from ...
Researchers have found a new way to produce human blood cells in the lab that mimics the process in natural embryos. University of Cambridge scientists used human stem cells for the studies. The ...
Amazon may have defeated ‘dodgy’ Firestick developers – spelling trouble for British people relying on the apps for cheap, illegal streaming. The retail giant launched its Fire TV Stick 4K Select this ...
Oct 11 (Reuters) - Andrew Tulloch, co-founder of Mira Murati's Thinking Machines Lab, has left the AI company to join Meta Platforms (META.O), opens new tab, the Wall Street Journal reported on ...
The Internal Revenue Service (IRS) on Thursday announced annual inflation adjustments for dozens of tax provisions, along with changes made under the One Big Beautiful Bill Act (OBBBA). The IRS' ...
Tesla has unveiled cheaper models of two of its most popular cars in the US as it tries to boost sales on the heels of the expiration of a key US tax credit. But the carmaker's shares tumbled about 4% ...
In recent days, RBC Capital downgraded American Tower (NYSE: AMT), citing near-term lease risks from Verizon's high-rent relocation approach ahead of a master lease expiration with the company. While ...
The Internal Revenue Service issued guidance on the corporate alternative minimum tax in response to comments it received. On Tuesday, the IRS released Notice 2025-49, which provides interim guidance ...
President Donald Trump has announced a slew of programs aimed at saving Americans money on prescription drugs, including a new website that will allow patients to buy them directly at discounted rates ...
American Tower (AMT) has found itself back in the investing spotlight, as a recent shift in its share price has caught more than a few eyes. There has not been one dramatic headline or seismic event.
UniQure Gene Therapy’s Clinical Trial Results Keep It on Path to Become First Huntington’s Treatment
A uniQure gene therapy slowed progression of Huntington’s disease by 75% after three years, statistically significant clinical trial results the company says will support plans for a regulatory ...
(RTTNews) - uniQure N.V. (QURE), a gene therapy company, on Wednesday announced that it has entered into a $175 million non-dilutive senior secured term loan facility with a specialty finance company, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback